Factors Affecting BAT Activation in PET/CT

Launched by ASSIUT UNIVERSITY · Oct 9, 2022

Keywords

ClinConnect Summary

This clinical trial is designed to study how certain factors can affect the activation of brown adipose tissue (BAT) during a specific imaging test called PET/CT, which uses a special type of sugar to help doctors see different tumors in the body. The goal is to understand how BAT behaves in patients with various types of tumors, which could improve future imaging techniques and treatments.

To participate in this study, you need to be between the ages of 65 and 92 and have a diagnosed tumor. You should also be able to understand the study and give your consent to participate. Some people might not be eligible if they have high blood sugar levels, uncontrolled diabetes, or if they feel anxious in tight spaces (claustrophobia), which can make it hard to complete the PET/CT scan. The study is not currently recruiting participants, but it aims to gather valuable information that could benefit patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • This study will include all patients presented with different types of tumors.
• • patients conscious to provide informed consent
• Exclusion Criteria:
• • • Patients who have contraindications to PET/CT scanning such as: a blood glucose level higher than 150-200 mg/dL, uncontrolled diabetics.
• • Intolerance of PET/CT due to claustrophobia will be excluded from the study.
• • Patients under age of 18